Filter
170
Text search:
Bedaquiline
Featured
Recommendations
28
New Publications
51
Language
Document type
No document type
110
Studies & Reports
21
Guidelines
19
Manuals
8
Fact sheets
5
Strategic & Response Plan
3
Situation Updates
2
Training Material
1
Infographics
1
Countries / Regions
Western and Central Europe
16
Eastern Europe
14
India
12
Global
4
Uganda
3
South Africa
3
Latin America and the Carribbean
3
Asia
3
Ethiopia
2
Germany
2
Zambia
2
Namibia
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Russia
2
Nigeria
1
Philippines
1
Nepal
1
Kenya
1
Bangladesh
1
Malawi
1
Ukraine
1
Botswana
1
Paraguay
1
Estonia
1
Romania
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
39
Clinical Guidelines
32
Public Health
3
Pharmacy & Technologies
2
Key Resources
1
Toolboxes
TB
120
HIV
5
AMR
4
NTDs
4
Polio
3
Pharmacy
3
Caregiver
2
Health Financing Toolbox
2
Global Health Education
1
COVID-19
1
Исследование этого года основано на предыдущем отчете. В нем отслеживается утверждение последних стратегий, руководств и методов в пяти сферах: диагностика и иссл
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘
...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h
...
To meet our Strategy objectives and get within reach
of the 2030 SDG 3 target related to the three diseases,
the Global Fund needs to raise US$18 billion for the
Eighth Replenishment. That sum is essential to drive the
required pace of progress in the fight against HIV, TB
and malaria, and to m
...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go
...
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success.
The NTLP is
...
The Best Buys for Disease Elimination is a practical, evidence-based guide to the most effective actions for countries to implement in order to eliminate communicable diseases. The guide highlights the efficient use of resources and prioritizing populations in vulnerable situations.
“The Region
...
In an era of constrained resources and tightening budgets, strategic prioritization in tuberculosis (TB) programming is more critical than ever. Countries must make informed decisions to allocate limited resources effectively - maximizing impact, preventing avoidable deaths, and sustaining progress
...
